Home
>
National Drug Code (NDC)
>
SUSTIVA
SUSTIVA - 0056-0474-92 - (efavirenz)
Drug Information of SUSTIVA
| Product NDC: | 0056-0474 |
| Proprietary Name: | SUSTIVA |
| Non Proprietary Name: | efavirenz |
| Active Ingredient(s): | 200 mg/1 & nbsp; efavirenz |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SUSTIVA
| Product NDC: | 0056-0474 |
| Labeler Name: | Bristol-Myers Squibb Pharma Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020972 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980917 |
Package Information of SUSTIVA
| Package NDC: | 0056-0474-92 |
| Package Description: | 90 CAPSULE, GELATIN COATED in 1 BOTTLE (0056-0474-92) |
NDC Information of SUSTIVA
| NDC Code | 0056-0474-92 |
| Proprietary Name | SUSTIVA |
| Package Description | 90 CAPSULE, GELATIN COATED in 1 BOTTLE (0056-0474-92) |
| Product NDC | 0056-0474 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | efavirenz |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 19980917 |
| Marketing Category Name | NDA |
| Labeler Name | Bristol-Myers Squibb Pharma Company |
| Substance Name | EFAVIRENZ |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |
